1. Home
  2. VRAX vs JNVR Comparison

VRAX vs JNVR Comparison

Compare VRAX & JNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • JNVR
  • Stock Information
  • Founded
  • VRAX 2013
  • JNVR 2018
  • Country
  • VRAX United Kingdom
  • JNVR United States
  • Employees
  • VRAX N/A
  • JNVR N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • JNVR Finance: Consumer Services
  • Sector
  • VRAX Health Care
  • JNVR Finance
  • Exchange
  • VRAX Nasdaq
  • JNVR Nasdaq
  • Market Cap
  • VRAX 7.3M
  • JNVR 7.3M
  • IPO Year
  • VRAX 2022
  • JNVR 2023
  • Fundamental
  • Price
  • VRAX $1.66
  • JNVR $5.29
  • Analyst Decision
  • VRAX
  • JNVR
  • Analyst Count
  • VRAX 0
  • JNVR 0
  • Target Price
  • VRAX N/A
  • JNVR N/A
  • AVG Volume (30 Days)
  • VRAX 236.4K
  • JNVR 18.8K
  • Earning Date
  • VRAX 02-05-2025
  • JNVR 03-27-2025
  • Dividend Yield
  • VRAX N/A
  • JNVR N/A
  • EPS Growth
  • VRAX N/A
  • JNVR N/A
  • EPS
  • VRAX N/A
  • JNVR N/A
  • Revenue
  • VRAX $84,872.00
  • JNVR $1,820,969.00
  • Revenue This Year
  • VRAX $5,169.18
  • JNVR N/A
  • Revenue Next Year
  • VRAX $66.97
  • JNVR N/A
  • P/E Ratio
  • VRAX N/A
  • JNVR N/A
  • Revenue Growth
  • VRAX 7.03
  • JNVR N/A
  • 52 Week Low
  • VRAX $0.60
  • JNVR $3.37
  • 52 Week High
  • VRAX $9.00
  • JNVR $11.84
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 42.25
  • JNVR 49.60
  • Support Level
  • VRAX $1.56
  • JNVR $4.88
  • Resistance Level
  • VRAX $1.86
  • JNVR $5.61
  • Average True Range (ATR)
  • VRAX 0.19
  • JNVR 0.63
  • MACD
  • VRAX -0.04
  • JNVR -0.03
  • Stochastic Oscillator
  • VRAX 26.31
  • JNVR 24.18

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About JNVR Janover Inc.

Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.

Share on Social Networks: